In one paragraphArticle in Vaccines, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from itWhat it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
13 authors.
Samuel BosomprahBasic Sciences and Immunology, Centre for Infectious Disease Research in Zambia, Lusaka 10101, Zambia.ORCID 0000-0002-2826-3887 Fraser LiswanisoBasic Sciences and Immunology, Centre for Infectious Disease Research in Zambia, Lusaka 10101, Zambia.ORCID 0000-0002-7257-9491 Bernard PhiriBasic Sciences and Immunology, Centre for Infectious Disease Research in Zambia, Lusaka 10101, Zambia.
Mwelwa ChibuyeBasic Sciences and Immunology, Centre for Infectious Disease Research in Zambia, Lusaka 10101, Zambia.ORCID 0000-0002-7609-9698 Charlie C LuchenBasic Sciences and Immunology, Centre for Infectious Disease Research in Zambia, Lusaka 10101, Zambia.
Harriet Ng'ombeBasic Sciences and Immunology, Centre for Infectious Disease Research in Zambia, Lusaka 10101, Zambia.
Kennedy ChibesaBasic Sciences and Immunology, Centre for Infectious Disease Research in Zambia, Lusaka 10101, Zambia.ORCID 0000-0002-9539-4756 Dennis NgosaBasic Sciences and Immunology, Centre for Infectious Disease Research in Zambia, Lusaka 10101, Zambia.ORCID 0009-0002-6338-4841 Mutinta MuchimbaBasic Sciences and Immunology, Centre for Infectious Disease Research in Zambia, Lusaka 10101, Zambia.ORCID 0000-0003-3163-712X Amanda K DebesJohns Hopkins Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD 21205, USA.
Roma ChilengiBasic Sciences and Immunology, Centre for Infectious Disease Research in Zambia, Lusaka 10101, Zambia.ORCID 0000-0003-0221-9527 David A SackJohns Hopkins Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD 21205, USA.ORCID 0000-0002-9338-5119 Caroline C ChisengaBasic Sciences and Immunology, Centre for Infectious Disease Research in Zambia, Lusaka 10101, Zambia.ORCID 0000-0002-7850-7915 Funding
This research was funded in whole or in part by Science for Africa Foundation to the Developing Excellence in Leadership, Training and Science in Africa (DELTAS Africa) programme DEL-22-012 with support from Wellcome Trust and the UK Foreign, Commonwealth DEL-22-012, 5R01AI123422
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
antibodiescholeraShanchol™vibriocidalwaning
Identifiers
PMID41746068
PMCPMC12945247
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390